Despite not representing a diagnostic criterion for WHO 2016 GBM classification, the identification of EGFR modifications (and specifically EGFRvIII) may have prognostic and therapeutic implications (even though the exact prognostic meaning of EGFRvIII is still controversial) [57,58,59]. Here, EGFR is linked to glioblastoma.